Marc Ladanyi

55PUBLICATIONS
567CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer geneticsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Jul 30, 2026
Microsatellite Instability Identifies a Rare but Clinically Relevant Subset of Sarcomas: Insights from the Largest Clinically Sequenced Cohort with Therapeutic Implications.

|Apr 22, 2026
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.

|Mar 11, 2026
FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy.

Daniel E Gracilla, Shruti Menon, Marcus R Breese

|Mar 04, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Anton Safonov, Minna Lee, David N Brown

|Jan 16, 2026
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236.

Alexander J Pfeil, Tom Zhang, Ryan Cheng

|Dec 12, 2025
Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer.

Avantika Gupta, Andrea Gazzo, Pier Selenica

Pageof 10

Frequent Collaborators

18 joint publications

Michael F Berger

9 joint publications

David B Solit

9 joint publications

Chad Vanderbilt

9 joint publications

Angela Rose Brannon